CR2Cancer: a database for chromatin regulators in human cancer

@article{Ru2018CR2CancerAD,
  title={CR2Cancer: a database for chromatin regulators in human cancer},
  author={Beibei Ru and Jianlong Sun and Yin Tong and Ching Ngar Wong and Aditi Chandra and Acacia Tsz So Tang and Larry Ka-Yue Chow and W. L. Wun and Z. Levitskaya and Jiangwen Zhang},
  journal={Nucleic Acids Research},
  year={2018},
  volume={46},
  pages={D918 - D924}
}
Abstract Chromatin regulators (CRs) can dynamically modulate chromatin architecture to epigenetically regulate gene expression in response to intrinsic and extrinsic signalling cues. Somatic alterations or misexpression of CRs might reprogram the epigenomic landscape of chromatin, which in turn lead to a wide range of common diseases, notably cancer. Here, we present CR2Cancer, a comprehensive annotation and visualization database for CRs in human cancer constructed by high throughput data… Expand
A framework for identifying dysregulated chromatin regulators as master regulators in human cancer
TLDR
An integrated framework based on multi-omics data to identify candidate master regulatory CRs affected by genomic alterations across eight cancer types in The Cancer Genome Atlas and revealed that the connectivity between TFs and their target genes (TGs) tended to be disrupted in the patients who had a high expression of oncogenic CRs or low-expression of tumor-suppressive CRs. Expand
Multilevel prioritization of gene regulators associated with consensus molecular subtypes of colorectal cancer.
TLDR
Integrative analysis identified a core set of 235 functional gene regulators to regulate core tumorigenic processes/pathways across CMSs, and systematic exploration of datasets using genomic and transcriptome co-similarity reveals the coordinated manner in FGRs act in CMSs to orchestrate their pathways and patients' prognosis. Expand
MR4Cancer: a web server prioritizing master regulators for cancer
TLDR
A user‐friendly and powerful web tool that will provide researchers novel insights into tumorigenesis and therapeutic intervention, MR4Cancer provides dynamic network visualization for MR‐target relations, and users can interactively interrogate the network to produce new hypotheses and high‐quality figures for publication. Expand
LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance.
TLDR
A classic workflow for lncRNA expression network analysis is presented, providing guidance for non-bioinformaticians to identify significant correlation between lncRNAs and other biomolecules. Expand
Proteotoxic stress-induced Nrf1 transcriptional program requires a functional TIP60 complex
TLDR
This study provides a framework for manipulating the Nrf1-TIP60 axis to alter proteasome function in various human diseases including cancer. Expand
Nrf1-mediated transcriptional regulation of the proteasome requires a functional TIP60 complex
TLDR
This study provides a framework for manipulating the TIP60–Nrf1 axis to alter proteasome function in various human diseases, including cancer. Expand
Computational resources for identification of cancer biomarkers from omics data.
TLDR
This review summarizes the various computational resources and tools housing several types of omics data related to cancer and focuses on providing comprehensive information on the open-source multiomics tools and data repositories, owing to their broader applicability, economic-benefit and usability. Expand
CYP2D6 EXPRESSION IS CUMULATIVELY UP REGULATED IN MULTIDRUG TREATED HEPATOMA CELLS: A PREDECTIVE PHARMACOGENETICS IN VITRO MODEL
Cancer and many other diseases require concomitant treatments with combinations of many drugs.Debrisoquine 4-Hydroxylayase (CYP2D6) is microsomal enzyme involved in phase I metabolism of a long listExpand
AMPK: An Epigenetic Landscape Modulator
TLDR
The role of AMPK as a mediator of cellular survival through its regulation of chromatin remodeling and the implications this has for health and disease are focused on. Expand
The role of pharmacogenomics in adverse drug reactions
TLDR
ADRs can be reduced not only by adherence to prescribing guidelines, suitable monitoring and regular medication review, but also by the implementation of pharmacogenomic procedures in the clinical setting. Expand
...
1
2
...

References

SHOWING 1-10 OF 65 REFERENCES
Inference of transcriptional regulation in cancers
TLDR
An efficient and accurate computational framework, RABIT (regression analysis with background integration), was developed and comprehensively integrated public transcription factor (TF)-binding profiles with TCGA tumor-profiling datasets in 18 cancer types and revealed many previously unidentified aspects of transcriptional regulation in tumor progression. Expand
EpiFactors: a comprehensive database of human epigenetic factors and complexes
TLDR
EpiFactors is a manually curated database providing information about epigenetic regulators, their complexes, targets and products, and is practical for a wide range of users, including biologists, pharmacologists and clinicians. Expand
CR Cistrome: a ChIP-Seq database for chromatin regulators and histone modification linkages in human and mouse
TLDR
The CR Cistrome database was constructed, available online at http://compbio.tongji.edu.cn/cr and http://cistrome.org/cr/, to further elucidate CR functions and CR-HM linkages and is believed to be a valuable resource for the epigenetics community. Expand
A global assessment of cancer genomic alterations in epigenetic mechanisms
TLDR
An unbiased approach confirms previously published data, uncovers novel cancer-associated aberrations targeting epigenetic mechanisms, and justifies continued monitoring of chromatin-related alterations as a class, as more cancer types and distinct cancer stages are represented in cancer genomics data repositories. Expand
Inferring regulatory element landscapes and transcription factor networks from cancer methylomes
TLDR
ELMER (Enhancer Linking by Methylation/Expression Relationships), an R-based tool that uses DNA methylation to identify enhancers and correlates enhancer state with expression of nearby genes to identify transcriptional targets, is described. Expand
The mutational landscape of chromatin regulatory factors across 4,623 tumor samples
TLDR
Two chromatin regulatory factors, MLL and EP300, correlate with broad expression changes across cancer cell lines, thus presenting at least one mechanism through which these mutations could contribute to tumorigenesis in cells of the corresponding tissues. Expand
An integrative pan-cancer-wide analysis of epigenetic enzymes reveals universal patterns of epigenomic deregulation in cancer
TLDR
This study demonstrates that there exist universal patterns of epigenomic deregulation that transcend cancer types, and that intra-tumor levels of genome-wide DNA hypomethylation and hypermethylation are controlled by distinct processes. Expand
TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes
TLDR
TSGene 2.0, which is the only available database for TSGs, provides the most updated TSGs and their features in pan-cancer. Expand
Modeling gene regulation from paired expression and chromatin accessibility data
TLDR
The purpose of the present work is to show that, by modeling matched expression and accessibility data across diverse cellular contexts, it is possible to recover a significant portion of the information in the missing data on binding locations and chromatin states and to achieve accurate inference of gene regulatory relations. Expand
HIstome—a relational knowledgebase of human histone proteins and histone modifying enzymes
TLDR
HIstome is a browsable, manually curated, relational database that provides information about human histone proteins, their sites of modifications, variants and modifying enzymes that will be useful for epigeneticists, pharmacologists and clinicians. Expand
...
1
2
3
4
5
...